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tropicalis; C. glabrata + C. kefyr and those with 3 Candida 
species colonization. 
Conclusions: This casual relationship between prominent 
Candida colonization and adverse impact on short-term 
mortality especially, in patients with hematological cancer 
and BMT recipients was not surprising. High mortality in 
patients with C. glabrata and C. krusei multiple sites 
and/or multiple species colonization was documented. 
Invasive aspergillosis with predominant thyroid and 
myocardial involvement 
L. Elzi, G. Laifer, M. Mayr, U Fluckiger 
Division of Infectious Diseases, Division of 
Nephrology, University Hospital, Base& Switzerland 
Invasive aspergillosis (IA) is a common fungal infection 
in immunocompromised patients with a high mortality 
rate. We report the case of a 49-year old man with history 
of fever and chills 4 months after kidney transplantation. 
Physical examination and chest radiography were 
normal. Laboratory tests showed CRP elevation (78 
mg/l). Blood cultures and urine bacteriology were sterile. 
Cytomegalovirus-antigenemia negative. Computed 
tomography (CT) of the chest discluded a small nodular 
lesion (1,2 cm) in the left lower lobe. No pathogenic 
organism was identified by bronchoalveolar lavage. 
Serology for toxoplasmosis and cryptococcal antigen 
were negative. Control CT of the chest 2 weeks later 
revealed minimal progression of the pulmonary lesion 
and an in-homogenous enlargement of the thyroid 
gland. Fine needle aspiration of the thyroid revealed 
growth of Aspergillus jumigatus. Inspite of anti-fungal 
therapy with liposomal Amphotericin B the patient 
remained febrile. Echocardiography and MRI of the 
heart showed fibrotic pericarditis and several myocardial 
abscesses, suggesting disseminated IA. Caspofungin and 
flucytosine was added to amphotericin B. Flucytosine 
was stopped after 2 weeks because of leukopenia. 
Three months after the therapy of amphotericin B and 
caspofungin, we observed favourable clinical course, 
regression of the pulmonary lesions and vanishing of the 
myocardial abscesses. The patient was discharged on oral 
itraconazole. In conclusion, we report an unusual clinical 
presentation of invasive aspergillosis with multiple myo- 
cardial abscesses in an immunocompromised patient 
with favourable outcome under experimental antifungal 
combination therapy. 
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Objectives: To receive a database, which is a basis for 
realization of effective preventive and empiric therapy 
of severe fungal infections in PTS with HM. 
Methods: The monitoring for selection of yeasts from 
different samples (urine, throat, blood, stool and others) 
during 2000-01 was performed. The standard techniques 
of microbiological research were used. The strains were 
identified by the selective medium (CROMagar, Becton 
Dickinson), “Auxacolor” (BIO-RAD) too. Susceptibility 
tests to antifungal drugs (6 agents) were performed with 
“Fungitest” (BIO-RAD). In our study BACTEC 9050 
blood culture system (Becton Dickinson Diagnostic 
instrument Systems) was used (Blood specimens were 
inoculated into BACTEC Mycosis-I(X). 
Results: A total of 590 strains from 294 PTS with HM 
between 2000 and 2001 were obtained. From 316 samples 
fungi were isolated in 8.9 % of cases in association (more 
than one strain from the same sample). 21 positive blood 
cultures from 14 PTS were obtained (only Candida spp., 
64% of them were non-albicans Candida species). There 
were 3 genera of yeasts in our hospital. Among them 
Candida spp, Geotrichum spp., Saccharomyces spp.. 
Candida spp represented 93.7% of all yeast isolates 
(C. albicans - 67.3%, C. glabrata - 8.2%, C. inconspicua 
- 7.0%, C. kefur - 3.1%, C. tropicalis - 2.9%, C. 
parapsilosis - 2.7%) C. krusei - 0.9%, C. lusitaniae - 
0.7%, C. rugosa - 0.4%, C. lipolytica - 0.2%). Non- 
albicans Candida species represented 28.2% of all 
Candida spp. We performed susceptibility tests of yeasts. 
No strain of yeasts was resistant to amphotericin B. 
Susceptibility testing of fungi revealed that the majority 
of the strains were sensitive to fluconazole, itraconazole, 
ketoconazole, miconazole, 5-fluorocytosine. 
Conclusion: The results of this study demonstrate that 
the predominant pathogens were Candida spp.. All 
strains of yeasts were susceptible to amphotericin B. 
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We investigated the in vitro susceptibility of Aspergillus 
fumigatus to 2-d rug combination of amphotericin B lipid 
complex (ABLC) and liposomal amphotericin B (L- 
AMB) with caspofungin (CFG) and micafungin (MFG), 
and the results were compared with those obtained for 
pair-wise combination of conventional amphotericin B 
(C-AMB) with CFG and MFG. Conidial suspensions 
were prepared from 20 clinical isolates of A. fumigatus 
(Microbiology Laboratory, Detroit Medical Center, 
Detroit,Michigan) susceptible to ABLC (MIC 1.26k1.14 
kg/mL), L-AMB (MIC 1.950.87 kg/mL) C-AMB (MIC 
l(O.0 kg/mL), and CFG (MIC 64kO.O kg/mL) and MFG 
(MIC 217.6261.82 kg/mL).The in vitro susceptibility of 
